WSSFN 2021

Short Biography: Edward Chang is the Joan and Sanford Weill Chair and Jeanne Robertson Distinguished Professor of Neurological Surgery at the University of California, San Francisco. Dr. Chang’s clinical expertise is surgical therapies for epilepsy, pain, and brain tumors. He specializes in advanced neurophysiologic brain mapping methods, including awake speech and motor mapping, to safely perform neurosurgical procedures in eloquent areas of the brain. His research focuses on the discovery of cortical mechanisms of high-order neurological function in humans. Dr. Chang’s laboratory has demonstrated the detailed functional organization of the human speech cortex and has translated those discoveries towards the development of a speech neuroprosthetic device to restore communication for people living with paralysis. Dr. Chang is the 2015 Blavatnik National Laureate in Life Sciences and member of the National Academy of Medicine.

Short Biography: G. Courtine is Professor of Neurosciences at the Ecole Polytechnique Fédérale de Lausanne (EPFL), and Adjunct Professor in the neurosurgical department of the University Hospital Lausanne (CHUV) and Faculty of Medicine and Biology of the University of Lausanne (UNIL). Together with functional neurosurgeon Prof. Jocelyne Bloch, he founded and lead the Defitech Center for Interventional Neurotherapies, named .NeuroRestore. .NeuroRestore develops neurotherapies involving surgical interventions to improve recovery from neurological disorders. G. and Jocelyne also founded ONWARD Medical to scale up their neurotherapies to widely available clinical treatments. G. is Chief Scientific Officer (CSO) of ONWARD Medical N.V., which is now traded on Euronext (ONWD).

Short Biography: Dr. Haseltine is a Neuroscientist whose research focused on sensory physiology and brain plasticity. After completing post-doctoral training in Neuroanatomy at Vanderbilt University, he applied his expertise in sensory physiology to the aerospace industry, before moving to Disney where he developed Virtual Reality displays for theme parks. Dr. Haseltine was Executive Vice President in charge of R&D at Disney when he was recruited to run the Research Directorate at NSA after 9/11, then was promoted to oversee science and technology for the entire US Intelligence community as its first CTO. He is currently CEO of Discovery Democracy, a startup that makes sophisticated industrial sensors. A named inventor on 67 patents and neuroscience journalist for Psychology Today, he is the author of 5 books, including the Amazon Bestseller, The Spy in Moscow Station.

Short Biography: Peter Konrad, MD PhD is the Chair of the Department of Neurosurgery at West Virginia University and JW Ruby Professor of Neuroscience and Neurosurgery in the Rockefeller Neuroscience Institute. He completed graduate degrees from Purdue University in Biomedical Engineering and Physiology developing device technology for cardiac implants (MS ’85) and motor systems physiology (PhD ’88) under Presidential Medal of Technology Awardee – Dr. Leslie Geddes. He became very interested in implantable medical device technology and neural engineering and sought to become a neurosurgical expert in the field of neurological implants. After completing medical school from Indiana University in 1991, he went on to Vanderbilt for neurosurgical residency and finished in 1997.

 

Dr. Konrad remained at Vanderbilt from 1998 until 2020, where he grew one of the largest clinical programs in deep brain stimulation (DBS) and functional neurosurgery. During his time at Vanderbilt, Dr. Konrad was able to mentor over 37 graduate students and clinical fellows in all areas of neurological devices and neuroscience research. He developed partnerships with numerous colleagues internationally in neuromodulation and neurological device research. He brings 22 years of federal and industry funded research experience as well as over 110 peer reviewed publications in the field of functional neurosurgery and neural engineering. He has served as advisor to the Congress of Neurological Surgeons on medical devices and was a Board of Director member of the American Association of Stereotactic and Functional Neurosurgery. Presently after 17 years on the Board of the North American Neuromodulation Society (NANS), he is the immediate past-president of the society.

 

In 2020, Dr. Konrad accepted the Executive Director of Clinical Translational Neuroscience position at the RNI and in 2022 was named as Chair of the Department of Neurosurgery within the Institute. Dr. Konrad continues to have a passion for clinical translational research, especially in neurological device technology. Beyond the application of new technology to clinical neuroscience, Dr. Konrad is charged with helping lead neurological device research across the breadth of the Institute. In doing so, he enjoys mentoring students and faculty, acknowledging that innovation in healthcare depends on seeing through the eyes of discovery in others.

Short Biography: Dr. Lozano is a neurosurgeon and University Professor at the University of Toronto. He is best known for his work in the field of Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS). His team has mapped cortical and subcortical circuits in the human brain and has advanced novel treatments for Parkinson’s disease and for depression, dystonia, anorexia, Huntington’s and Alzheimer’s disease.
Dr. Lozano has over 750 publications and serves on the boards of several international organizations. He has trained over 70 international post-doctoral fellows. He has received a number of honors including Doctor Honoris Causa from the University of Sevilla, the Olivecrona Medal, the Pioneer in Medicine Award and the Dandy Medal. He has been elected to the Royal Society of Canada, has received the Order of Spain and is an Officer of the Order of Canada.

Short Biography: Dr. Morishita is an Associate Professor and chief of functional neurosurgery unit in the Department of Neurological Surgery at Fukuoka University Faculty of Medicine, Fukuoka, Japan. He serves as an active board member for academic societies such as World Society for Stereotactic and Functional Neurosurgery and The Japanese Congress of Neurological Surgeons. He is also an editor for scientific journals including World Neurosurgery and Frontiers in Human Neuroscience.

Dr. Morishita’s clinical practice covers a wide variety of neurological disorders, including movement disorders, intractable pain, spasticity, epilepsy, and stroke. His primary research interest is in neuroimaging analysis of neuronal circuits associated with deep brain stimulation (DBS) for movement and neuropsychiatric disorders. Especially, he is highly recognized for the connectomic studies visualizing 3D neuronal networks associated with electrical stimulation fields. His research projects have been supported by JSPS (KAKENHI) and other foundations. He is actively working to expand the application of functional neurosurgical procedures to new fields.

Short Biography: Frank Rudzicz is a scientist at the Li Ka Shing Knowledge Institute at Unity Health Toronto, Director of Artificial Intelligence at Surgical Safety Technologies Inc., an associate professor of Computer Science at the University of Toronto, co-founder of WinterLight Labs Inc., faculty member at the Vector Institute for Artificial Intelligence, and CIFAR Chair in Artificial Intelligence. His work is in machine learning in healthcare, especially in natural language processing, speech recognition, and surgical safety. His research has appeared in popular media such as Scientific American, Wired, CBC, and the New York Times, and in scientific press such as Nature.``

Short Biography: Russell R. Lonser received his M.D. from Loma Linda University. Upon completion of his residency the University of Utah (2001), he joined the staff of the Surgical Neurology Branch at the National Institutes of Health (NIH). He was Chief of the Surgical Neurology Branch at NIH before becoming Professor and Chair of the Department of Neurological Surgery at Ohio State University in 2012. He holds the Dardinger Family Chair in Neurosurgical Oncology.

Dr. Lonser’s research interests include development of drug delivery paradigms for the central nervous system pathology. He is an author on over 350 scientific and clinical publications. He received the Tumor Young Investigator Award from the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors (2001) and Mahaley Clinical Research Award from the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors (2013). He was the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors Bittner Lecturer (2017) and the American Academy of Neurological Surgery Edward H. Oldfield Lecturer (2018).

His contributions to organized neurosurgery include membership on the Executive Committee of the Congress of Neurological Surgeons. He was the Treasurer and President of the Congress of Neurological Surgeons. He is the Secretary of the American Board of Neurological Surgeons. He was the head of the Research Subcommittee in Head, Neck and Spine Injury Committee for the National Football League for 10 years. He has been actively involved in the mentoring and training of over 40 neurosurgical fellows. He has served on the Editorial Boards for NEUROSURGERY, World Neurosurgery and Journal of Neurosurgery. He is Academic Editor for PLoS One and Science Reports. He is Consulting Editor for Neurosurgery Clinics of North America and Associate Editor for Neurosurgery. He has edited 4 drug delivery and neurosurgical textbooks.

Short Biography: Professor Joachim K. Krauss is Director and Chairman of the Department of Neurosurgery at Hannover Medical School, Germany, since 2005. He received his MD degree at the Medical Faculty of the University of Freiburg, Germany, for his experimental work in neuropharmacology of the basal ganglia. He trained in neurology, and later in stereotactic and functional neurosurgery, and general neurosurgery with Professors Mundinger and Seeger in Freiburg. Thereafter, he moved to Houston, Texas, to collaborate with Drs Grossman and Jankovic. He went back to Europe to establish functional neurosurgery in Berne, Switzerland, and in Mannheim, Germany, where he served as Vice Chairman from 1999 to 2005. His clinical routine includes functional neurosurgery, complex spine, skull base, microvascular decompression, neurooncology and hydrocephalus.
Prof. Krauss has been President of the European Society for Stereotactic and Functional Neurosurgery (ESSFN) from 2010 to 2014, and of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) from 2013 to 2017. He also served as President of the German Academy for Neurosurgery from 2018 to 2019. He is an active member of several international societies, committees and advisory boards. One of his missions is to bridge the gap between Neurosurgery and Neurology why he is also active in the Movement Disorders Society where he served as chair/ co-chair in several tasks forces and working groups: Neurosurgery; Deep Brain Stimulation for Dystonia; Neuromodulation for Gait and Normal Pressure Hydrocephalus.
He has published more than 600 scientific manuscripts and book chapters, and he has edited four books in the field of functional neurosurgery. He introduced pallidal deep brain stimulation for cervical dystonia in 1997, and spinal cord stimulation for orthostatic tremor in 2002. He received several awards including the Oppenheim prize for his work in dystonia. In the past few years he put a particular focus on education and training. He is a member of the ESSFN training committee and chair of the WSSFN training committee.

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, India
Positions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFN
Member: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: Born in Kyiv, and educated at Ukrainian State Medical University (1988-1994)
Residency training program in neurosurgery 1994 – 1997 at Romodanov Neurosurgery Institute, Kyiv. Training included research fellowship at the Laboratory of experimental neurosurgerywhere he obtained his PhD in 1999. Dr. Kostiuk assumed his appointment in the Department of Functional Surgery in 1994, and has been on the surgical staff at the Romodanov Neurosurgery Institute since that time.
Fellowship, observership: Georg-August-University in Gottingen (1995), Gayar Bayar University Hospital in Manisa (1997), Hospital na Homolce, Prague, (2000), John Radcliffe Hospital Oxford University (2009), Toronto Western Hospital (2013), Foundation Rothschild Hospital, Paris (2015). Scientific Degree of Doctor of Medical Sciences of Ukraine, 2012 (thesis: “Differentiated neurosurgical treatment of epilepsy)”. In March 2011, Dr. Kostiuk was appointed to the position of the head of department of Functional Neurosurgery and Neuromodulation.
Vice-president of Ukrainian League Against Epilepsy, Member of the Executive Committee of ESSFN Practice interests: epilepsy surgery, stereotactic functional neurosurgery, neuromodulation, neurooncology, radiosurgery, psychosurgery.
Publiations: 218

Short Biography: Dr Jonker has a combined practice of stereotactic and functional neurosurgery and neurooncology.
His practice includes all aspects of stereotactic and functional neurosurgery (movement disorder surgery, trigeminal neuralgia surgery, cancer pain surgery, stereotactic radiosurgery, epilepsy surgery) and brain and pituitary tumour surgery.
He is the principal neurosurgeon for the St Vincent’s General and Private Hospital Movement Disorder Unit.
He is a board member of the Neurosurgical Society of Australasia and a clinical senior lecturer at the University of Sydney.
With his neurology and neuroradiology collaborators he established the first MRI guided focused ultrasound treatment centre in Australia and has performed well over 100 MRgFUS thalamotomies.

Short Biography: Prof. Juan A. Barcia is currently Professor and Head of the Department of Neurosurgery at the University Hospital "Hospital Clínico San Carlos" in Madrid, Spain, and Chair in Neurosurgery at the Universidad Complutense de Madrid. Board certified in Neurosurgery since 1992, he received his MD in 1987 and PhD in 1996. He has been Associate professor of Neurosurgery at the University of Valencia; Head of Clinical Division, Service of Neurosurgery at the Hospital General Universitario de Valencia; Head of the laboratory of Neural Regeneration and Neural Repair of the Centro de Investigación Príncipe Felipe in Valencia, and Scientific Director of the Research Foundation at the Hospital General Universitario de Valencia. He received his doctorate from the University of Valencia and completed his residency in neurosurgery at the Hospital Clinico Universitario de Valencia, extending studies of functional neurosurgery at the Karolinska Hospital in Stockholm, Sweden, and of epilepsy surgery at the Montreal Neurological Institute in Canada.

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, India
Positions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFN
Member: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: Dr. Sitnikov was born 26 of August, 1977 in Amursk area (Russia). Completed medical degree in 2001 at Far East Medical University (Khabarovsk, Russia) and subspecialized in neurosurgery at the Sklifosovsky Research Institute in Moscow. From January 2007 works at Federal Centre of Treatment and Rehabilitation of Ministry of Healthcare as a Chief of Neurosurgical Department. In 2009 he got an MD degree with research in microvascular decompression for surgical treatment of hemifacial spasm. In 2015 he registered the Association of Functional Neurosurgeons aiming the close collaborating with international Societies and colleagues. From 2017 the Russian Association of Functional Neurosurgeons recognized as an official branch of WSSFN in Russian Federation. In 2017 Dr. Sitnikov was elected as a Board Director and Continental vice-president of WSSFN during the WSSFN Congress in Berlin.

Short Biography: Michael C. Park, MD, PhD, is a neurosurgeon who works with patients suffering from movement disorders (Parkinson's disease, essential tremor and dystonia), epilepsy, depression and pain. Dr. Park sees patients at the M Health Fairview Clinics and Surgery Center - Minneapolis, Neurosurgery Clinic, and performs his surgeries at the University of Minnesota Medical Center, where he specializes in neuromodulation. He performs numerous treatments, including but not limited to, deep brain stimulation, lesionectomy, amygdalohippocampectomy, response neural stimulation, vagus nerve stimulation, laser ablation, spinal cord stimulation and gamma knife radiosurgery. He is an Associate Professor with the University of Minnesota Medical School's Department of Neurosurgery and he is the Neurosurgery Department's Residency Program Director. He is also the Director of Stereotactic and Functional Neurosurgery. From a research standpoint, Dr. Park focuses primarily on neuromodulation (deep brain stimulation) and he is a collaborator, Principal Investigator or Co-Principal Investigator in numerous active, ongoing projects in that field. In addition, he is a Clinical Core Co-Investigator for the U of M’s Udall Center of Excellence for Parkinson's Disease Research.

Short Biography: Bart Nuttin is full professor at KU Leuven Belgium. He is chief of clinic, neurosurgeon, at University Hospitals Leuven. He was born in 1959, is married and has 4 children. He obtained the MD degree at KU Leuven in 1984, and became specialist in neurosurgery in 1992. He defended his PhD thesis (promoter Prof. J. Gybels) in 1996. He trained also in Pretoria, South-Africa (1982), Exeter, England (1986), Köln, Germany (1994) and was visiting lecturer on the neurosurgical service at Children's Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, US in 1994. He is chair of the Task Force on Neurosurgery for Psychiatric Disorders of the World Society for Stereotactic and Functional Neurosurgery (WSSFN), and has been member of the board of directors of WSSFN, vice-president for Europe WSSFN, treasurer of European Society for Stereotactic and Functional Neurosurgery, president of the Belgian Society for Stereotactic and Functional Neurosurgery, president of the Benelux Neuromodulation Society and member of the Council of the "Europäische Akademie zur Erforschung von Folgen wissenschaftlich-technischer Entwicklungen Bad Neuenahr-Ahrweiler GmbH" and member of several national and international societies. He is member of the committee of neurosurgery for psychiatric disorders in Belgium. He was research coordinator of the Group of Biomedical Sciences at KU Leuven and before that, ombuds for PhD students. He was coordinator of the Erasmus Mundus project EMMAPA. He has / had several research contracts or Chairs with Medtronic, Boston Scientific, 3WIN, the European Commission, the Research Council of the University, the Flemish Government (SBO) and the “Fonds voor Wetenschappelijk Onderzoek, Vlaanderen (FWO)”. He is and has been leading a series of master degree theses and PhD theses. He has published many times in international peer reviewed high impact journals.

Short Biography: Ryoong Huh, MD, PhD Dept. of Neurosurgery, Neuroscience Center Incheon St. Mary's Hospital The Catholic University College of Medicine Current position Professor of Dept. of Neurosurgery, The Catholic University of Korea College of Medicine Director of Neuroscience Center of Incheon St. Mary’s Hospital Education Background 1989 MD. Soonchunhyang University, College of Medicine 2002 PhD. Yonsei University Graduate School Professional Background 1997-1999 Dept. of Neurosurgery, Severance Hospital, Yonsei University College of Medicine Clinical fellow 1999-2000 Dept. of Neurosurgery, Bongsaeng Hospital Staff 2000-2011 Dept. of Neurosurgery, Bundang CHA Hospital CHA University College of Medicine Assistant, Associate Professor, Professor 2004-2005 Dept. of Neurosurgery, OHSU Hospital Oregon Health Science University Visiting Professor 2011-Present Dept. of Neurosurgery, Incheon St. Mary's Hospital The Catholic University of Korea College of Medicine Professor 2016-Present Director of Neuroscience Center of Incheon St. Mary’s Hospital Society Activity 2007-2011 Board Member of The Korean Neurosurgical Society 2009-2012 Committee Member of examination, insurance of The Korean Neurosurgical Society 2009-present Review Board of Journal of Korean Neurosurgical Society 2011-2014 Secretary General of Korean Society of Stereotactic and Functional Neurosurgery 2011 Secretary General of AASSFN 2011 2013-2015 Secretary General of Korean Pain Study Association 2017-2019 President of Korean Society of Intraoperative Neuro-Monitoring 2018-2019 President of Korean Society of Stereotactic and Functional Neurosurgery 2021- WSSFN Ex Officio – Korea 2021- WSSFN Continental Vice President - Korea

Short Biography: Haruhiko KISHIMA M.D., Ph.D. Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine. Education: 1985-1991 Osaka University, School of Medicine M.D., awarded 5/1991 1994-1998 Dept. of Neurosurgery, Osaka University Graduate School of Medicine. Ph.D., awarded 3/1998 Professional Training and Employment; 1991-1992 Resident in Neurosurgery, Osaka University Hospital. 1992-1993 Resident in Neurosurgery, Osaka Kouseinenkin Hospital. 1993-1994 Medical Staff in Neurosurgery, Wakakusa Daiichi Hospital. 1998-2000 Medical Staff in Neurosurgery, Kobe Ekisaikai Hospital. 2000-2001 Assistant Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine. 2001-2002 Faisant Fonction Interne in Neurochirurgie, CHU Hôpital Henri Mondor, Céteil, France. Director, Prof. Y. Keravel 2002-2003 Post-doctral fellow, URA CEA CNRS 2210 Service Hospitalier Frédéric Joliot, Orsay, France Director, P. Hantraye and Dr. S. Palfi 2003-2010 Assistant Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine. 2010- Associate Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine. 2017- Professor and Chairman, Department of Neurosurgery, Osaka University Graduate School of Medicine. 2021- Director, International Medical and Engineering Information Center, Osaka University Specialty Functional neurosurgery, Epilepsy Surgery, Brain tumor Neuromodulation, Neuroimmunology Societies: The Japan Neurosurgical Society The Japanese Congress of Neurological Surgeons Japanese Society for Stereotactic and Functional Neurosurgery Japan Epilepsy Society International Neuromodulation Society Society for Neuroscience Asian-Australasian Society for Stereotactic Functional Neurosurgery Asia Epilepsy Surgery Congress

Short Biography: Nader Pouratian is Professor and Chair of Neurological Surgery at UT Southwestern Medical Center in Dallas, Texas. In his clinical practice, he uses advanced neurotechnologies to improve brain and spine function for neurological and psychiatric disease, including Parkinson’s, tremor, pain, depression, obsessive compulsive disorder, and blindness. His research aims to understand brain diseases and to develop targeted therapies. He take advantage of unparalleled opportunities presented by neurosurgery to study human brain function and design novel neurotechnologies. His work is supported by several NIH grants. Finally, he is passionate about training future leading neurosurgeon-scientists.

Short Biography: TBA

Short Biography: TBA

Short Biography: He is an ex-professor of functional neurosurgery in Hamamatsu University. In 2020 He became the chairman of both Japanese society for Stereotactic and Functional neurosurgery and Japan Neuromodulation Society.
He is now a deputy hospital director and a chief neurosurgeon of Toyoda Eisei Hospital. In which he is doing Focused ultrasound therapy."

Short Biography: Given Name: Jung-Il
Family Name: Lee
Gender: Male
Present Post: Professor
Department of Neurosurgery, Samsung Medical Center Sungkyunkwan University School of Medicine
Education
1982-86 College of Medicine, Seoul National University
1989-93 Neurosurgical Residency, Department of Neurosurgery, Seoul National University Hospital
1993-94 Neurosurgical Fellow, Department of Neurosurgery, Seoul National University Hospital
Professional Career
1994- Faculty, Department of Neurosurgery, Samsung Medical Center, Seoul Korea
1997-1999 Research Fellow, Neurological Surgery, Johns Hopkins University, Baltimore, Maryland USA
2007- Professor, Department of Neurosurgery, Sungkyunkwan University
School of Medicine, Seoul Korea
2009-2019 Director, Brain Tumor Center, Samsung Medical Center
2009-2010 President, Korean Gamma Knife Radiosurgery Society
2014.3-2015.3 President, Korean Society of Stereotactic and Functional Neurosurgery
2015.4-2017.3 President, Korean Society of Intraoperative Monitoring
2015-2020.9 Board member, Asian Australasian Society of Stereotactic & Functional Neurosurgery (AASSFN)
2016.3-2017.3 President, Korean Stereotactic Radiosurgery Society
2017.11- Board member, Asian Leksell Gamma Knife Society
2020.9 - President, Asian Australasian Society of Stereotactic & Functional Neurosurgery (AASSFN)
2021.4- Chairman, Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
Specialty
Stereotactic and functional neurosurgery, Radiosurgery, Neurooncology

Short Biography: Dr Avecillas-Chasin is assistant professor of the department of neurosurgery at the university of Nebraska medical center. He is a stereotactic and functional neurosurgeon with interest in basal ganglia and white matter anatomy. Currently, his research and clinical practice is mainly focused on personalized neuromodulation therapies using brain mapping techniques to prospectively target symptom-specific networks. Dr Avecillas-Chasin received his medical degree from the university of Guayaquil in Ecuador and his PhD at the universidad complutense de Madrid in Spain. He completed his neurosurgery residency training in Madrid-Spain at the Hospital Clinico San Carlos. After completing his residency training, he completed subspecialized training in neurosurgical oncology and radiosurgery at the Cleveland clinic, and stereotactic and functional neurosurgery at the Vancouver general hospital in Canada and Mount Sinai Health System in New York. Dr Avecillas-Chasin is involved in multiple national and international research collaborations and has received several grants and awards including the “young neurosurgeon award” by the World Federation of Neurosurgical Societies (WFNS) in 2016 and the “Stereotactic and functional young neurosurgeon clinical award” by the Congress of Neurological Surgeons (CNS) in 2021 for his work on personalized neuromodulation therapies. Dr Avecillas-Chasin has published over 40 peer-review publication including journal articles, book chapters, and other online resources such as the tractography atlas “Subcortical White Matter Pathways Avecillas 2019”. His most recent work on the human amygdala circuit was awarded and featured in the brain initiative contest “The art of the brain” by the national institute of health (NIH): https://www.braininitiative.org/achievements/the-art-of-the-brain-snapshots-from-the-2021-contest/#mapping.

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, India
Positions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFN
Member: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: Dr. Honey is Professor and Head of the Division of Neurosurgery at the University of British Columbia. He obtained his medical degree from the University of Toronto and his doctoral degree from Oxford University as a Canadian Rhodes Scholar. He completed his Royal College training in neurosurgery in Vancouver in 1995 and became a diplomat of the American Board of Neurological Surgeons in 2000. He has completed an additional year of training at Harvard Medical School and is a Scholar in Surgical Leadership.
His research is focused on the treatment of movement disorders and pain. He headed the world’s first trial of DBS for spasmodic dysphonia and published the results in 2021. He was the first physician to recognize and successfully treat hemi-laryngopharyngeal spasm (HELPS syndrome) in 2014. He discovered and successfully treated the first person in the world with VANCOUVER syndrome in 2019. He has made fundamental changes to the understanding of human pain pathways.
In 2016, Dr. Honey was elected the President of the Canadian Neuromodulation Society (2016-2019). In 2018, Dr. Honey was elected President of the World Neurosurgical Federation for Cranial Nerve Disorders. This group studies conditions such as Trigemnial Neuralgia, Hemifacial Spasm, Glossopharyngeal Neuralgia and the newly described Hemi-Laryngopharyngeal Spasm (HELPS) and has a major interest in Microvascular Decompression (MVD) neurosurgery. Dr. Honey will host the 3rd World Congress of this Society in Vancouver in 2022.

Short Biography: • Student of Medical School, Chelyabinsk Municipal Medical Academy (September 1990 - June 1996);
• Nurse, Chelyabinsk Regional Clinical Hospital, Intensive Care Unit (October 1993 - May 1996);
• Junior resident, internship, Chelyabinsk Regional Clinical Hospital, Surgical Department (August 1996 - June 1997);
• Neurosurgeon-neurotraumatologist, Chelyabinsk Regional Clinical Hospital, neurosurgical Department (September 1997 - August 2000);
• Senior resident, Neurosurgical Polenov Institute and Multifield Hospital #2, Neurosurgical Department (September 2000-June 2002);
• Attendant doctor, City Multifield Hospital #2, Neurosurgical Department (July 2001- September 2005);
• Chief resident, St-Petersburg Medical Academy of Postgraduate Education, neurosurgical faculty (October 2002 -June 2005);
• Deputy Head Doctor, Autonomous Non-profit Organization «Medical Center «Twenty First Century» (September 2002 - September 2004);
• Deputy Director, Autonomous Non-profit Organization “International Neurogroup” (April 2002 - September 2004);
• Resident, City Multifield Hospital #2, Neurosurgical Department (July 2001 - September 2005);
• Neurosurgeon, Neurosurgical Department of Russian Research Institute of Traumatology and Orthopedics named after prof. R.R. Vreden (September 2005 - May 2012);
• Physician-in-Chief, Neurosurgeon, the Federal Neurosurgical Center, Novosibirsk, Russia (May 2012 till present).

Short Biography: Faisal Alotaibi is a professor of neurological surgery at King Faisal Specialist & Research Centre , Alfaisal University in Riyadh, Saudi Arabia. He obtained his neurosurgical training in epilepsy surgery at the Western University in Canada and stereotactic neurosurgery at the London Health Sciences Centre in Canada and a Fellow of the American College of Surgeons. After which, he joined King Faisal Specialist & Research Centre in Riyadh and Alfaisal University.
Currently, Dr. Alotaibi is a founding board member of the International Epilepsy Surgery Society IESS and the president of Saudi epilepsy society. He joined the board director of the World Society of Stereotactic and Functional Neurosurgery -WSSFN. He is an active member of several local and international societies, committees, and executive boards. He is the founding member and the former president of the Gulf League Against Epilepsy, GLAE. He is an editor and reviewer in local and international journals. He is involved in several local and regional task forces and committees to promote the field of epilepsy and Functional neurosurgery in Saudi Arabia and the region. His main research interests include clinical and basic studies on the treatment of and modulation of functional neurological disorders and other neuroscience research.

Short Biography: Prof. Dr. med Claudio Pollo is deputy chief physician (Stv. Chefarzt) at the Neurosurgery Department of the University Hospital Bern and head of the stereotactic & functional and epilepsy neurosurgery.
During his training, he concentrated his clinical and research interests on stereotactic, functional and epilepsy neurosurgery under the mentorship of Prof JG Villemure at the Univserity Hospital Lausanne. He also spent one year research fellowship in functional neurosurgery in the department of Prof AL Benabid in Grenoble. In 2003, he obtained a master in biomedical engineering at the Swiss Federal Institute of Technology (EPFL) in Lausanne.
The most part of his research projects sustained by peer reviewed national and international grants are focused with a special interest on DBS or EEG modelling as well as development of new technologies, in particular probabilistic imaging- and sensing-based DBS planning and programming using directional DBS systems, for modulating brain function in movement, pain and psychiatric disorders. His scientific work has been recognized by more than 100 peer reviewed international publications. He is co-founder of Aleva Neurotherapeutics, a swiss company dedicated on a new segmented DBS system, as well as actively involved in Epios, a swiss company focused on wireless EEG long term monitoring.

Short Biography: Susan J. Harkema, PhD, Professor, holds the Owsley B. Frazier Rehabilitation Chair in Neurological Surgery and is the Associate Director of the Kentucky Spinal Cord Injury Research Center at the University of Louisville. Over the last 27 years, her research has focused on neural plasticity of spinal networks and recovery of function after spinal cord injury. Her more recent studies have shown that people with chronic paralysis can regain the ability to voluntarily move their legs and stand independently while also recovering cardiovascular and bladder function with epidural stimulation. This broadened the scope of the translational research program to include technology development to improve implantable epidural stimulators.
Dr. Harkema leads the KSCIRC translational faculty within the Pediatric NeuroRecovery, Adult NeuroRecovery, and Epidural Stimulation Programs. Over the past decade, these programs have collectively been awarded over $72 million in research dollars with the aim to improve motor, cardiovascular and bladder function, health, and quality of life of adults and children living with paralysis. During that time, she also led six rehabilitation centers and nine community fitness and wellness centers in the translation of scientific knowledge into clinical practice as the Director of the Christopher and Dana Reeve Foundation NeuroRecovery Network.
Dr. Harkema’s research interest has been understanding neural mechanisms of the human spinal circuitry that initially focused on locomotion and began with a model of diagnosed motor clinically complete spinal cord injury. Over the years, serendipitous discoveries expanded and allowed her to take advantage of her graduate degree in physiology to unravel mechanisms of the human spinal circuitry that modulate the autonomic nervous system. She has maintained an NIH funded research program since 1998 and she has been funded by grants from the NINDS, NCRR, NIBIB; as well as the DOD, the Christopher and Dana Reeve Foundation, the Paralyzed Veterans Administration, Wings for Life and the Craig H. Neilsen Foundation.
During her career, she has published more than 110 scholarly manuscripts and book chapters; delivered over 100 worldwide lectures and keynotes; been a grant reviewer for the NIH, Roman Reed, Mission Connect, FISM Society; and she has sat on numerous advisory boards and review panels. It is important to note that many of her 18 mentored graduate students and post-doctoral fellows have excelled in their careers.
In addition to the above accomplishments, Dr. Harkema has co-authored seven United States patents and received several honors and awards throughout her career. In 2007, the National Spinal Cord Injury Association nominated her into the SCI Hall of Fame for Achievement in Research in Quality of Life; 2008, she was a co-recipient of the Reeve-Irvine Research Medal which is awarded to individuals who have made critical contributions to promoting repair of the damaged spinal cord and recovery of function; 2011, she received the Difference Maker Award from the Rick Hansen Foundation as well as the Breakthrough Award from Popular Mechanics; 2012, she received the John Stanley Coulter Award for significant contribution to the field of rehabilitation by the ACRM; 2014, she received the Innovator of the Year award from Business First; 2018, the Paul J. Corcoran, MD Distinguished Lecture from Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School; and in 2019, she again received the Innovator of the Year award from Business First.
Dr. Harkema earned her Bachelor of Science and PhD from Michigan State University and conducted her postdoctoral fellowship in neurophysiology at the University of California, Los Angeles.

Short Biography: TBA

Short Biography: G. Courtine is Professor of Neurosciences at the Ecole Polytechnique Fédérale de Lausanne (EPFL), and Adjunct Professor in the neurosurgical department of the University Hospital Lausanne (CHUV) and Faculty of Medicine and Biology of the University of Lausanne (UNIL). Together with functional neurosurgeon Prof. Jocelyne Bloch, he founded and lead the Defitech Center for Interventional Neurotherapies, named .NeuroRestore. .NeuroRestore develops neurotherapies involving surgical interventions to improve recovery from neurological disorders. G. and Jocelyne also founded ONWARD Medical to scale up their neurotherapies to widely available clinical treatments. G. is Chief Scientific Officer (CSO) of ONWARD Medical N.V., which is now traded on Euronext (ONWD).

Short Biography: Dr. Horisawa has authored numerous research papers and received various international and domestic academic awards. His main research interests include the application of deep brain stimulation and ablative procedures (radiofrequency, gamma knife, and focused ultrasound) using the Forel’s field (pallidothalamic tract) to involuntary movements, epilepsy, and psychiatric disorders and deep brain stimulation using the cerebellum for involuntary movements.

Short Biography: Ahmed M. Alkhani, MD, FRCSC, IFAANS. Fellow of the Royal College of Physicians and Surgeons of Canada American Board of Neurological Surgery University of Toronto Fellowship in Stereotactic & Functional Neurosurgery Professor (Adj.), School of Medicine, Alfaisal University Consultant & Head of Neurosurgery, King Abdulaziz Medical City, Ministry of National Guard, Health Affairs (MNG-HA). Riyadh, Saudi Arabia Personal e-mail: alkhani@yahoo.com, Hospital e-mail: alkhaniah@ngha.med.sa Current Appointment: Sep. 2019- present Head, Neurosurgery Department of Neurosurgery, KAMC, NGHA Riyadh, Saudi Arabia Oct. 2016- present Full Professor (adj.), College of Medicine Alfaisal University, Riyadh, Saudi Arabia Jan. 2020 – present Head Scientific Council, Neurosurgery Program Saudi Commission for Health Specialties (SCFHS) Jan. 2022- present Chairman, Stereotactic & Functional Neurosurgery committee World Federation of Neurosurgical Societies WFNS Oct. 2018- present Head, educational committee, Pan-Arab Neurosurgical Society. Sep. 2017- present Continental Vice-president World Society for Stereotactic and Functional Neurosurgery Jan. 2016 – present Founder President Middle-eastern Society for Stereotactic & Functional Neurosurgery MSSFN. Apr. 2015- present Member, Psychiatric surgery Task force, WSSFN. PUBLICATIONS: More than 50 publications in peer review journals. ABSTRACTS: More than 200 accepted abstracts in national and international scientific meetings. PRESENTATIONS: More than 200 presentations in national and international scientific meetings.

Short Biography: Joseph Neimat grew up in the Washington DC area. He studied at Dartmouth College and Duke University. Dr. Neimat performed his residency in Neurosurgery at Massachusetts General Hospital, and a fellowship in Neuromodulation surgery at the University of Toronto, with Dr. Lozano, a pioneer in that field. In 2006, he joined the Department of Neurosurgery at Vanderbilt University, where he was Director of Epilepsy and was a founding member of the Institute for Surgery and Engineering. In 2016 Dr. Neimat transitioned to the University of Louisville where he serves as Chairman of Neurological Surgery. His clinical interests include the surgical treatment of movement disorders, the treatment of epilepsy, novel therapies for disorders of mood and behavior, and the multi-modality treatment of complex pain. Dr. Neimat additionally runs a collaborative research lab exploring cognitive and emotional processing in cortical and subcortical structures. The lab uses the opportunity of DBS and epilepsy surgeries, to evaluate the response of neuronal ensembles to novel stimuli that task cognitive and emotional processing. Dr. Neimat has served on the Board of Directors for the American and World Societies for Stereotactic and Functional Neurosurgery (ASSFN and WSSFN). He currently serves as the President of the ASSFN.

Short Biography: Dr. Machado is the Chairman of the Neurological Institute and the Charles and Christine Carroll Family Endowed Chair in Functional Neurosurgery. Dr. Machado performs deep brain stimulation (DBS) surgery for patients with Parkinson’s disease, tremor, dystonia and obsessive-compulsive disorder as well as surgical procedures for patients with trigeminal neuralgia, intractable pain syndromes and spasticity.
Dr. Machado is a Professor of Neurosurgery at the Cleveland Clinic Lerner College of Medicine and has Joint Appointments in the Departments of Neuroscience and Biomedical Engineering. He is the past Chairman for the Joint Pain Section of the CNS/AANS and Vice-President of the American Society of Stereotactic and Functional Neurosurgery.
Dr. Machado is an Associate Chief of Staff at Cleveland Clinic and leads several enterprise-level projects with the Office of the Chief of Staff, including innovations in the model of care and a new program for professional career development.
Dr. Machado received his medical degree from the University of Sao Paulo in 1997. He completed his residency in the same institution in 2003 and obtained his Ph.D. in 2004. He came to the Cleveland Clinic in 2004, completed his fellowship in Stereotactic and Functional Neurosurgery in 2006 and has been on the staff of the Cleveland Clinic since then.
Dr. Machado leads several deep brain stimulation and neuromodulation clinical trials as well as laboratory research. His research in deep brain stimulation for thalamic pain syndrome was awarded the National Institutes of Health Director’s New Innovator’s Award. His current research, funded the NIH BRAIN initiative is aimed at developing novel treatments to promote rehabilitation after stroke and traumatic brain injury.

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, India
Positions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFNMember: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: Education and Training
1984 - 1988 College of Medicine, Seoul National Univ., Seoul Korea(M.D. degree)
1994 - 1996 Graduate School, Seoul National Univ., Seoul, Korea(M.S. in Medical Science)
1996 - 2001 Graduate School, Seoul National Univ., Seoul, Korea(Ph.D. in Medical Science)
1992- 1996 Residency in Neurosurgery, Seoul National Univerv. Hospital, Seoul, Korea
1996 - 1997 Clinical Fellowship in Neurosurgery, Seoul National Univerv. Hospital, Seoul, Korea
1997 - 1999 Clinical Fellowship in Neurological Surgery, Asan Medical Center, Seoul, Korea
2002 – 2003 Research Fellowship in Neurological Surgery, University of Southern California Hospital
Professional Experience
1999 – 2001 Instructor of Neurological Surgery, Asan Medical center, Univ. of Ulsan College of Medicine, Seoul, Korea
2001 – 2006 Assistant Professor of Neurological Surgery, Asan Medical center, Univ. of Ulsan College of Medicine, Seoul, Korea
2006 – 2011 Associate Professor of Neurological Surgery, Asan Medical Center and Univ. of Ulsan College of Medicine, Seoul, Korea
2011 - present Professor of Neurological Surgery, Asan Medical Center and Univ. of Ulsan College of Medicine, Seoul, Korea
Research Interests: Spine Disorder, Movement Disorder, Stem Cell Therapy
Present Position
2014 - present The member of Neurotrauma Committee of Asian Australasian Society of Neurological Surgeons
2016 - present Vice-President, Asia-Oceania Neurotrauma Society (AONTS)
2017.9 - present The member of council board of International Association of Neurorestoratology (IANR)
2019.11- present Board member of Neurotraumatology Committee of World Federation of Neurosurgical Societies (WFNS)
2021.9 - present President of Korean stereotactic and functional neurosurgery society

Short Biography: Konstantin Slavin, MD, FAANS is Professor, Chief of Section and Fellowship Director for Stereotactic and Functional Neurosurgery in the Department of Neurosurgery at the University of Illinois at Chicago (UIC).
Dr. Slavin graduated from medical school in Baku, Azerbaijan in the Soviet Union and completed his neurosurgery residency in Moscow. He then completed his second neurosurgery residency at UIC and a fellowship in functional and stereotactic neurosurgery at Oregon Health Sciences University in Portland, OR.
Dr. Slavin is the Past President of the American Society for Stereotactic and Functional Neurosurgery and current Vice-President of the World Society for Stereotactic and Functional Neurosurgery. He is also the President-Elect of the International Neuromodulation Society (INS) and past Secretary of the North American Neuromodulation Society (NANS). For many years, he was an Executive Committee member of the Joint Section on Pain of the American Association of Neurological Surgeons and Congress of Neurological Surgeons
Dr. Slavin’s work is published in many books and peer-reviewed journals and is an associate editor or editorial board member for a number of publications, including Neuromodulation, Neurosurgery, Brain Sciences, Stereotactic and Functional Neurosurgery, Acta Neurochirurgica and others; he is the current editor-in-chief of Progress in Neurological Surgery. His first book on Peripheral Nerve Stimulation was published in 2011; another book, co-edited with Sam Eljamel on Neurostimulation: Practice and Principles, came out in 2013; the third one, Stimulation of Peripheral Nervous System: The Neuromodulation Frontier was released in 2015. The most recent book on Neuromodulation for Facial Pain came out in 2021.

Short Biography: His interest in neurosciences started early during first year of med school in University of São Paulo (USP) driving him into a 5-year-experience in the neurophysiology lab under the supervision Prof. Cesar Timo-Iaria (one of the founders of discipline neurophysiology/neurosciences in Brazil) when he was exposed to stereotaxic method and performed several chronic micro and LFP recording electrode implants in animal models to study brain oscillations in sleep and attention. Right after the medical degree in the same university (1998), started neurosurgery residency program at Hospital das Clinicas in USP under the supervision of Prof. Raul Marino Jr. (1999-2003), followed by a fellowship in Functional Neurosurgery (2004-2007) in the Division of Functional Neurosurgery in the same institution. Conducted the Ph.D. thesis with studies in the mechanism of motor cortex stimulation for pain in the Neurology Department at USP (2007) and won the Young Investigator Ward in the WSSFN Meeting in Rome in 2005. In 2009 he became Ph.D. supervisor (2009-Present) and became preceptor for functional neurosurgery fellowship and organized the first multidisciplinary DBS unity in Division of Functional Neurosurgery in the Institute of Psychiatry at USP having many fellows from different countries in Latin America. Conducted several experimental and clinical studies for different stereotactic, neuromodulation and DBS techniques for movement disorders and neuropsychiatric diseases. Founded the neuromodulation lab in Hospital Sírio-Libânes also in multidisciplinary context conducting studies in neuromodulation of pain and movement disorders. Received multiple research grants, published several scientific papers, book chapters and conferences in international meetings worldwide. Received the Full Professorship in Neurosurgery in 2012 studying the Effects of DBS in Motor & Non-Motor Symptoms of PD. In 2013, he progressed into the Position of Associate Professor of Neurosurgery in Neurology Dept at USP (2013-present). In 2014 became post-doc supervisor (2014 - present); presently is member of the board of directors in the WSSFN and LATAM and Brazilian Stereotactic and Functional Neurosurgery (SLANFE/BSSFN).

Short Biography: Dr. Hamani is Senior scientist at the Sunnybrook Research Institute, Research Director of the Hurvitz Brain Sciences Program, Preclinical lead of the Harquail Centre for Neuromodulation and Professor in Neurosurgery at the University of Toronto, Canada. His research involves the development of new ways of modulating the function of the nervous tissue, and discovering new applications for techniques that stimulate the brain and spinal cord to treat neurological and psychiatric disorders.

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, India
Positions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFN
Member: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: 1992 graduate form Showa medical University in Tokyo, Japan
1992-1994 internship, Tokyo Women’s Medical University, Dept. of Neurosurgery
1994-1997 Research fellow, Harvard Medical University, Brigham & Women’s Hospital, Children Hospital, Brain Tumor Research Center
2000 Board of the Japan Neurosurgical Society
2009 Associate Professor at Tokyo Women’s Medical University, Dept of Neurosurgery
Associate Professor at Tokyo Women’s Medical University,Faculty of Advanced
Techno-Surgery (FATS), Institute of Advanced Biomedical Engineering & Science
2016 Director of Training office at Tokyo Women’s Medical University, Cancer Center
2020 Neurosurgery Clinical Expert of ZAP surgical System, Inc.
2021 Chief of brain tumor division, Utsunomiya symphony hospital

Short Biography: Professor of Faculty of Advanced Techno-Surgery (FATS) and Department of Neurosurgery, Vice-President of Institute of Advanced Biomedical Engineering and Science, Director of Medical AI Center, Tokyo Women's Medical University (TWMU).
Dr. Muragaki joined the Department of Neurosurgery at Tokyo Women's Medical University in 1986 after his graduation from Kobe University. After he became a board neurosurgeon, he went on to study for basic research at the Department of Pathology and Laboratory Medicine, University of Pennsylvania between 1992 and -95.
He is actively working as a staff of Neurosurgical Department of TWMU, and then he has held concurrent posts as Professor at FATS of TWMU since 2011.　He has been a vice-director of Institute of Advanced Bio-Medical Engineering and a director of Medical AI Center of TWMU since 2019.
Dr. Muragaki has developed many medical devices including a smart operating theatre (SCOT), cutting-edge navigation, and novel therapy such as photodynamic therapy, and autologous tumor vaccine, and so on. He also conducts many clinical trials for malignant brain tumor and his team has highest volume of the patients with brain tumor.
Dr.Muragaki is a member of Japanese Neurosurgical Society, the Japan Society for Neuro-Oncolgy, Japanese Society for Medical and Biological Engineering, and an international member of American Association of Neurosurgical Surgeons. His publication articles, total number of citations, and H-index were 222, 3768, and 31, respectively.
He received several prizes following Sankei High-Tech Award (2004), Industry-Academia-Government, Minister of State for Science and Technology Prize (2010), Microsoft Innovation Award (2013), Chunichi Industrial Award (2015), and Japan Open Innovation Prize (2019).
SCOT:https://www.japan.go.jp/tomodachi/2019/spring-summer2019/cutting-edge_operating_theater.html

Short Biography: Director of Neurosurgery and Functional Neurosurgical program Jaslok Hospital
Group Advisor, Functional Neurosurgery, Apollo Group of Hospital, IndiaPositions:
President The Neuromodulation Society
Past President ISSFN
Board member: INS, WSSFN, AASSFN
Member: International task force for Psychiatric disorders Recipient of the first Medscape India award for excellence in neurosciences Recipient of Pharma Leaders Power Brand award-Excellence in Neurosciences, 2019. > 40 publications and >300 invited lectures

Short Biography: Born in Kyiv, and educated at Ukrainian State Medical University (1988-1994) Residency training program in neurosurgery 1994 – 1997 at Romodanov Neurosurgery Institute, Kyiv. Training included research fellowship at the Laboratory of experimental neurosurgerywhere he obtained his PhD in 1999. Dr. Kostiuk assumed his appointment in the Department of Functional Surgery in 1994, and has been on the surgical staff at the Romodanov Neurosurgery Institute since that time.
Fellowship, observership: Georg-August-University in Gottingen (1995), Gayar Bayar University Hospital in Manisa (1997), Hospital na Homolce, Prague, (2000), John Radcliffe Hospital Oxford University (2009), Toronto Western Hospital (2013), Foundation Rothschild Hospital, Paris (2015). Scientific Degree of Doctor of Medical Sciences of Ukraine, 2012 (thesis: “Differentiated neurosurgical treatment of epilepsy)”. In March 2011, Dr. Kostiuk was appointed to the position of the head of department of Functional Neurosurgery and Neuromodulation. Vice-president of Ukrainian League Against Epilepsy, Member of the Executive Committee of ESSFN Practice interests: epilepsy surgery, stereotactic functional neurosurgery, neuromodulation, neurooncology, radiosurgery, psychosurgery. Publiations: 218

Short Biography: Kai Miller is a native Californian who attended UC San Diego, where he played on the intercollegiate tennis team. He later attended the University of Washington for graduate school, obtaining a PhD in Physics, an MD, and a second PhD in Neuroscience. After completing his neurosurgery residency at Stanford University in California, he completed fellowships in epilepsy, deep-brain stimulation, and tumor resection in children and adults. Dr. Miller joined the neurosurgery staff at Mayo Clinic in Rochester in 2019. In addition to his clinical practice, Dr. Miller studies basic human neurophysiology and clinical translation for cybernetics, epilepsy and functional neurosurgery. His group, the Cybernetics and Motor Physiology Laboratory, is focused on the creation of new devices to 1) control cybernetic prostheses, 2) induce brain plasticity after injury, and 3) intervene with distributed circuits in neuropsychiatric disease and movement dysfunction.

Short Biography: TBA

Short Biography: Milad Girgis is the vice president and general manager for the global brain franchise, where he leverages his more than 25 years of experience in medical device product development, engineering, operations and marketing to oversee all commercial sales and marketing strategies for deep brain stimulation (DBS) and the company’s associated therapy partnerships. Milad has led our DBS business since its commercial start nearly 10 years ago in Europe. During his tenure with the company, he’s held notable positions such as leading manufacturing operations and commercial responsibilities for International Sales for Neuromodulation, where he led the expansion of Spinal Cord Stimulation (SCS) and the launch of DBS therapy in Europe, Japan, Latin America, Australia and Canada. Prior to BSC, Milad held manufacturing engineering roles with Medtronic within the diabetes business, as well as an R&D role at an in-vitro diagnostic company. Milad earned a bachelor’s degree in mechanical engineering and a master’s degree in engineering management from California State University, Northridge. He is also an alumnus of the Stanford Executive Education program, and holds four patents, two of which are directly related to the company’s SCS and DBS products.

Short Biography: Dr. Binith Cheeran is the Medical and Clinical Affairs Senior Director at Abbott Labs, a Clinical Neurologist and Ph.D. Neuroscientist. After training in Internal Medicine, he specialized in Neurology with sub-specialty expertise in Movement Disorders and Deep Brain Stimulation. In academic research, at University College London and Oxford University, Dr. Cheeran’s interests including basic science and applied clinical neuromodulation research for pain, movement disorders and psychiatric applications. At Abbott, his focus has been Digital Health and indication expansion. He is the executive sponsor for product development of Neurosphere Virtual Clinic, a first-in-class CE-marked, FDA approved, integrated telemedicine solution for neurostimulator programming, which was recently recognized by Time Magazine as one of the 100 best inventions of 2021.

Short Biography: Fred Haer graduated from Thiel College in Greenville, Pennsylvania in 1965 with a B.S. in Chemistry. In the following two years, he did graduate work in physical chemistry at the University of Michigan. From 1967 to 1969, he worked for two Ann Arbor companies in technical sales and marketing. In 1970, Jill and Fred Haer founded Frederick Haer and Company in Michigan; they moved the company to Brunswick, Maine in 1977 and Frederick Haer and Company was reincorporated as FHC, Inc. Currently 100 FHCers are employed at its corporate and manufacturing facilities in Bowdoin, Maine and field technical support offices in Greenville, PA; Bucharest, Romania; and Medellin, Colombia. FHC formation exactly parallels the growth of the Society for Neuroscience. Our products for clinical functional neurosurgery began 25 years later. FHC designs, manufactures, and internationally markets products for neuroscience, the study of the brain and nervous system, and neurosurgery. Its neuroscience customers are research scientists at universities, medical schools, research hospitals, and government research institutions around the world. Functional neurosurgeons use FHC’s medical devices for intraoperative microelectrode recording and stimulation in movement disorders and more recently epilepsy. Fulfilling a company BHAG created in 1991, FHC established the Greenville Neuromodulation Center (GNC) in July, 2013. The Center offers training for medical personnel and includes facilities for clinical and neuroscience research. FHC collaborative relationships with users and medical device partners has been responsible for all our products and company growth. The company has established Neural microTargeting™ Worldwide as its trademark and is committed to remain an independent Maine manufacturing company serving the communities in which it operates.

Short Biography: TBA

Short Biography: Ning, Yihua, Chairman and General manager, SceneRay Corporation Limited Yihua Ning, who has more than 30 years of experience in medical device engineering, sales, marketing and operations management, used to worked in GE HealthCare, Becton and Dickinson, Medtronic, Siemens and Densply China. Mr. Ning founded SceneRay in 2011. Mr. Ning was educated with Bachelor degree on Biomedical Engineering and Master Degree in Shanghai Fudan University, and Executive Master Degree on Business Administration in Cheung Kong Graduate School of Business in Beijing.

Short Biography: Dr. Jörn Rickert Chief Strategic & Scientific Officer Jörn Rickert studied biology in Hamburg and Freiburg. His dissertation on the representation of movement in the motor cortex made an important contribution to basic neurobiological research. When writing his dissertation, he also had the idea to use scientific research as a bridge for implementation and to start a business focusing thereon. After completing his PhD in 2004, he became project manager at the Brain Machine Interfacing Initiative (BMII) in Freiburg, undertaking the task of transferring the research results of this group of scientists into a marketable product. He founded CorTec in September 2010.